RecruitingNCT07282691
Validation of Clinical Outcome Measures Specific to mTBI-Related Oculomotor Disorders
Sponsor
Salus University
Enrollment
150 participants
Start Date
Apr 1, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The specific aim of this project is to validate clinical tests to be used as outcome measures in studies of mTBI-related vision problems.
Eligibility
Min Age: 18 YearsMax Age: 35 Years
Inclusion Criteria3
- Diagnosis of mTBI within previous 1 to 6 months
- Distance visual acuity better than or equal to 20/25 in each eye
- Score >21 on Convergence Insufficiency Symptom Survey
Exclusion Criteria4
- Diagnosis of moderate or severe TBI; > 30-min loss of consciousness
- Not wearing required refractive error)
- Disease(s) known to affect oculomotor system (multiple sclerosis, Graves orbitopathy, myasthenia gravis, diabetes mellitus, or Parkinson disease)-Manifest strabismus or intraocular injury (evaluated at vision examination)
- Cognitive delays that may impact testing
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07282691